SynthesisOrphanet journal of rare diseases2025
Cognitive and intellectual functioning in leukodystrophy patients: a systematic review.
Synthesis in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background'Leukodystrophies' encompass a group of genetic disorders affecting brain white matter, mostly characterized by neurological deterioration. Manifestations include mood changes, cognitive decline, motor dysfunction, and often early death. Underestimation of the cognitive decline may result in a lack of suitable interventions and adequate guidance. This systematic review aims to gain insight into available information on the cognitive and intellectual profile of leukodystrophy patients, providing a basis for further research.
methodsMEDLINE, EMBASE and PsychINFO were searched for studies examining processing speed, attention, memory, language, social cognition, visuospatial functioning and construction, and intelligence in patients with any type of confirmed leukodystrophy utilizing standardized neuropsychological tests. The included studies were analyzed to determine whether there are similarities among the various types of leukodystrophies and their associated cognitive and intellectual profiles. Due to significant variability in neuropsychological assessments, data synthesis was performed narratively rather than via meta-analysis.
resultsThirteen group studies and twenty case studies were included, with most group studies rated as moderate to high quality. On group level, cognitive and intellectual functioning varied widely between different leukodystrophy types. Intelligence and information processing speed were most frequently affected. A consistent finding was that the age of onset significantly influenced cognitive outcomes, with childhood-onset leukodystrophies generally associated with earlier and greater cognitive and intellectual impairments than adult-onset leukodystrophies.
conclusionAlthough intelligence and cognition are obviously affected in the course of leukodystrophies, information processing speed being impaired relatively frequently, the specific profiles of cognitive and intellectual impairment are currently unclear, while such insight is crucial for proper guidance. Well-designed future studies are needed to establish a clearer cognitive and intellectual profile in leukodystrophies, their subtypes and during their disease course. Results will be the basis for suitable guidelines for testing and set the foundation for development of appropriate outcome measurements for therapy trials.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.